Verdant Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 07-07-2024
- Paid Up Capital ₹ 20.35 Cr
as on 07-07-2024
- Company Age 16 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 43.13 Cr
as on 07-07-2024
- Satisfied Charges ₹ 12.50 Cr
as on 07-07-2024
- Revenue -3.30%
(FY 2022)
- Profit 5.79%
(FY 2022)
- Ebitda 221.84%
(FY 2022)
- Net Worth 3.52%
(FY 2022)
- Total Assets 13.41%
(FY 2022)
About Verdant Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 20.35 Cr.
The company currently has active open charges totaling ₹43.13 Cr. The company has closed loans amounting to ₹12.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Verdant Life Sciences Private Limited India is Umesh Vani as COMPANY SECRETARY. Dharma Ramineni, Sivarama Manne, and Ravindra Gogineni serve as directors at the Company.
- CIN/LLPIN
U24232AP2008PTC059563
- Company No.
059563
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jun 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Verdant Life Sciences Private Limited offer?
Verdant Life Sciences Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Blood System and Cardiovascular API, Antidepressant & Anti Anxiety Medicines, Sertraline Tablets.
Who are the key members and board of directors at Verdant Life Sciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Umesh Vani | Company Secretary | 01-Apr-2022 | Current |
Dharma Ramineni  | Managing Director | 26-Apr-2013 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sivarama Manne | Director | 27-Apr-2009 | Current |
| Ravindra Gogineni | Director | 27-Apr-2009 | Current |
Financial Performance and Corporate Structure Insights of Verdant Life Sciences.
Verdant Life Sciences Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 3.3% decrease. The company also saw a slight improvement in profitability, with a 5.79% increase in profit. The company's net worth moved up by a moderate rise of 3.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Verdant Life Sciences?
In 2022, Verdant Life Sciences had a promoter holding of 91.18% and a public holding of 8.82%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Mar 2022 | ₹2.63 Cr | Open |
Others Creation Date: 31 Jan 2022 | ₹5.00 Cr | Open |
Others Creation Date: 05 Oct 2020 | ₹4.50 Cr | Open |
How Many Employees Work at Verdant Life Sciences?
Verdant Life Sciences has a workforce of 139 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Verdant Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Verdant Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
